Introduction
Retroviral gene therapy has proven to be an efficient and promising approach for correcting certain inherited diseases such as severe combined immunodeficiency [1] [2] [3] and chronic granulomatous disease. 4 Retroviruses used in gene therapy studies efficiently infect human cells, and stably integrate their DNA into the human genome. 5 Yet, integrated vectors were found to be responsible for gene inactivation 6 and modification of expression levels of adjacent genes. 7, 8 Insertion-induced malignancy, termed 'insertional mutagenesis', is a known side effect of gene therapy. It has been reported not only in a mouse model, 9 but has shown to be a threatening complication in rhesus macaque 10 and human [11] [12] [13] gene therapy trials. To date, there is a pressing demand to better understand insertional mutagenesis and to assess its likelihood. To this end, protocols such as inverse PCR, 14, 15 linear amplification-mediated (LAM)-PCR, 16 or ligationmediated (LM)-PCR 17, 18 have been successfully used to detect genomic sequences flanking gene therapy vectors. Following the localization of these sequences in a genome ('mapping'), the insertion site, including its genomic adjacency, need to be analyzed ('profiling') by using graphical interfaces such as the ENSEMBL (http://www.ensembl.org) or UCSC genome browsers (http://genome.ucsc.edu), or by the aid of bioinformatical tasks such as IntegrationMap 19 or SeqMap. 20 This way, the insertion site profiles of gene therapy vectors based on avian sarcoma and leucosis virus, 21, 22 mouse mammary tumor virus, 23 human T-lymphotropic virus 1, 24 foamy virus, 25, 26 equine infectious anaemia virus, 27 human immunodeficiency virus, 21, [28] [29] [30] [31] [32] feline immunodeficiency virus, 33 murine leukemia virus 7, 8, 17, [34] [35] [36] [37] [38] [39] or simian immunodeficiency virus 35, 40, 41 were described by us and other groups.
Of note, tools enabling comprehensive meta-analyses have not been available, although more than 50 000 insertion site sequences flanking the above-named vectors are made available through public databases such as GenBank (http://www.ncbi.nlm.nih.gov/Genbank/ index.html). So far, these analyses are hampered because mapping procedures, profiling strategies, program settings and applied quality parameters are largely dependent on individual experiences, and thus vary from laboratory to laboratory. Besides the need for uniform meta-analyses, new public tools are also urgently needed to allow researchers handling hundreds of thousands of insertion site sequences that are generated by novel highthroughput methods, such as LM-PCR and pyrosequencing. 42, 43 This report describes the establishment of an analysis tool termed QuickMap (available at http://www.gtsg.org), which automatically maps FASTA-compiled insertion site sequences and determines frequencies of hits in chromosomes, fragile sites, genes, cancer genes, pseudogenes, transcription factor and (post-transcriptional) miRNA binding sites, CpG islands and repetitive elements (SINE, LINE, DNA elements/DNA transposons, simple and LTR elements). To determine whether integration profiles are statistically significant from random distributions, QuickMap compares these insertion frequencies to the data obtained from a random reference. Two approaches were tested to obtain this reference set: simulation and calculation of random insertion.
Results
Our goal was to establish an open-access, fast and easyto-use insertion site sequence analysis tool, which is not only capable of generating detailed insertion profiles, including information on numerous genomic features ( Figure 1 ), but also allows a fast detection of non-random insertion patterns by comparing profiles generated from insertion site analysis studies (that is, sequence sets) with the data obtained from analysis of a reference set.
Simulation versus calculation of random insertion
We first needed to obtain reliable random insertion frequencies and tested two approaches: simulation and calculation of random insertion. Random insertion was simulated by applying conditions known from sequence analysis protocols following inverse PCR, 14, 15 LAM-PCR 16 or LM-PCR 17,18 analysis. As expected, the widths of the corresponding 95% confidence intervals (CIs) shorten with increasing numbers of random sequences ( Figure 2) . With an increasing sample size, the calculated insertion frequency, which can be seen as a feature's (gene, CpG island, transcription factor binding sites, repetitive element) proportion on the whole genome, has shown to be comparable with the simulated insertion frequency when analyzing rarely appearing features, such as CpG islands (0.78% of the whole genome) or transcription factor binding sites (0.17%), only. In contrast to this, we observed a considerable discrepancy between calculated and simulated frequencies of hits in genes for sample sizes 410 000. The ENSEMBL annotated genes account for 37.6% of the whole human genome (http://www.ensembl.org/homo_sapiens/), which reflects their calculated insertion frequency, but they make up 39.9% of all integrations when simulating random insertion using a set of n ¼ 1 000 000 sequences. Similarly, we found repetitive elements (43% of the whole genome) to be targeted in a higher frequency when simulating random insertion with sample sizes 41000 sequences (46.9% for n ¼ 1 000 000 sequences).
QuickMap-mapping results
Following sequence submission at the web interface (http://www.gtsg.org), results of the mapping, that is, the localization of the insertion sites within the selected genome, are compiled in a compressed file termed MapperReport (Figure 3 44 and miRNA target sites predicted by miRanda 45 are found. The 'Repeat Feature Report' informs about insertions in/next to the interspersed type I (LINE/SINE), type II (DNA), LTR and RNA repeats. CpG islands and transfer RNA (tRNA) genes are automatically annotated and are stored as 'Simple Features' in the ENSEMBL database. We therefore designed a 'Simple Feature Report' to report on insertions in and in the proximity to these genomic features.
QuickMap-results of the analysis versus random
After filtering of redundant insertion sites within a submitted set, results of the analysis versus random are sent as zipped AnalyzerReport to the email address entered at the web interface dialogue. Similar to the MapperReport, the AnalyzerReport consists of five files: 'Basic Report', 'Gene Report', 'Regulatory Feature Report', 'Repeat Feature Report' and 'Simple Feature Report'. Each of these contains data of a statistical comparison between experimental (submitted by user, termed 'target set' in the reports) and data derived from a random insertion sequence set (n ¼ 1 000 000; termed 'reference set') in which the insertion frequency ('freq') and the lower and upper (95% CI (lower) and 95% CI (upper)) limits of the CIs are given.
All reports initially display a 'Front sheet', which contains the result of the quality ('blasted') and redundancy ('non-redundant') control and a 'Summary' sheet, reporting on vector hits 5, 50 and 250 kb adjacent to the corresponding features. The 'Basic Report' shows insertion distributions over all chromosomes (retroviral insertions on chromosomes; 'RISC'), within n ¼ 100 individual chromosomal slices ('Ext. RISC'), and in fragile sites. The analysis of hits in and close to genes Automated vector insertion site analysis J-U Appelt et al are presented in the 'Gene Report', and a 'Hit Genes Details' sheet gives detailed information about in-gene insertions (distance to transcription start site absolute/ relative, intron/exon insertion). The analysis of hits in and adjacent to one of the human cancer genes (annotated in the cancer gene census 46 ) or mouse cancer genes (annotated in the Retrovirus Tagged Cancer Gene Database 53 ) is compiled in the 'Cancer Genes' sheet. All analyses of insertions adjacent to genes ('Gene Report'), transcription factor binding sites/miRNA sites ('Regulatory Feature Report'), interspersed repeats ('Repeat Feature Report') and CpG/tRNA genes ('Simple Feature Report') are compiled in 'Adj' data sheets ( Figure 4 ).
Test sequence submission
To set benchmarks for mapping and analysis time, we subjected a total of 5739 murine leukemia virus and 152 426 human immunodeficiency virus insertion site sequences to QuickMap. We found a linear correlation between the number of sequences subjected to QuickMap and mapping time in the range between 100 and 1500 sequences ( Figure  5 ), whereas the mean mapping speed was 26.8 seq s -1 . Interestingly, when subjecting large sequence sets, for example, readouts of pyrosequencing runs, we saw a nearly 10 times higher mapping speed (267.4 seq s -1 ).
Discussion
Although several studies have contributed to a better understanding of retroviral vector insertion site selection, we saw the necessity to provide an open-access platform for fast and reliable real-time analyses of known and new insertion site sequences. This report describes QuickMap, an open-access analysis system, which allows fast and uniform mapping and analysis of gene therapy vector insertion sites.
Recently, insertion sequence trimming 19 and mapping tools have successfully developed and applied, 19, 20 which assign genetic loci to submitted sequences. Here, we wanted to address the needs of gene therapy researchers to explore a broader variety of genomic features and also to discover non-random patterns, especially regarding insertions in genes or cancer 0 LTR) into the host cell genome. As indicated here, host DNA is double stranded (+/À strand), whereas each strand can contain several genomic elements, such as genes, TSS, TFBS, CpG Islands, LINE, SINE, LTR elements or simple elements. These genomic features can either be disrupted by the vector ('hit'; GENE A), or lie in adjacency (Gene B). The size of a 'genomic window' around the insertion site is thereby termed 'slice' (here: +/À 250 kb). To determine whether a genomic feature is an attractive target for gene therapy vectors, distances ('D') to all features within a slice need to be calculated. Therefore, for each insertion, a variety of information about hit and adjacent features, including their distances to the insertion site are accumulated. TSS, transcription start sites; TFBS, transcription factor binding sites; SINE, short interspersed nuclear elements; LINE, long interspersed nuclear elements; CpG, CpG island; SIMPLE, simple DNA repeats.
Automated vector insertion site analysis J-U Appelt et al genes. 46 Thus, the first important obstacle to overcome was finding the appropriate strategy to differentiate how specific insertion patterns can be distinguished from purely random integration. We saw that a simulation, carried out using sequences that meet similar quality criteria as those derived from experimental (LM-PCR/ LAM-PCR) analysis, results in a more accurate insertion site distribution than a calculation, although random set sizes of 1000 to 10 000 sequences are not reliable to detect preferred or non-preferred features, regardless of which approach, simulated or calculated, was used. Most importantly, insertion frequencies in features that make up large parts of the human genome, such as genes, are underestimated by a calculation of 'randomness'. The reason for this finding lies in the bioinformatical assembly of the human genome; genes are well characterized genomic regions and several of them were fulllength sequenced and mapped long before the first drafts of the human genome were published in 2001. 47, 48 The likelihood that a coding sequence will be actually mapped is therefore considerably greater than that of non-coding sequences, which is finally reflected by a shift of simulated frequencies. In contrast to this, transcription factor binding sites and CpG island locations, the simple 'products' of automatic annotation, have not been extensively mapped or characterized earlier, which resulted in a convergence of frequencies.
QuickMap compiles results into two reports: MapperReport and AnalyzerReport. Thus, mapping raw data are stored separately from the random analysis, which on one hand allows us to obtain information about individual hit/adjacent features' names/IDs (for exanple, gene names and Ids) and facilitates data export of name/ID lists into other web tools, such as the functional annotation tool DAVID (http://david.abcc.ncifcrf.gov/). On the other hand, it is possible to separately obtain frequencies of hits in or in adjacency to a collection of features (for example, all 'hit genes' or 'Adj Genes') from the AnalyzerReport. Reporting on insertion frequencies of an analyzed vector in genes, transcription start site, CpG, SINE or LINE has become a standard in recent studies (reviewed in Bushman et al. 49 ). Graphs showing frequencies of individual features in the +/À 50-100 kb genomic neighborhood of an insertion site were constructed, whereas the graphs showing the high prevalence of transcription start site around murine leukemia virus insertions 34, 36, 50 are probably the most famous examples. We addressed this demand and included a graphical display of a +/À 250 kb adjacency around the experi- Figure 2 Random insertion calculation and simulation. We calculated the random insertion frequencies in (a) genes, (b) CpG islands, (c) transcription factor binding sites and (d) repetitive elements (pool of SINE, LINE, DNA elements and LTR elements) by evaluating the ratios of the chromosomal space occupied by these features compared to the length of the human genome (for example, number of all base pairs belonging to genes/all base pairs of the human genome). These calculated frequencies are drawn as horizontal lines in each graph. On the basis of the size of the random insertion site sets of a specific group, we also calculated 95% confidence intervals (CIs) for the calculated ratios and plotted them as gray boxes. In addition to the calculation, the mean frequencies obtained by a simulation (25 different sets for each size) are plotted as black dots together with the corresponding 95% CIs.
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J-U Appelt et al mental and random insertion sites into nearly all report sheets of the AnalyzerReport. Another major point we wanted to address was to enable fast analysis of large data sets arising from novel protocols such as LM-PCR and pyrosequencing. 42, 43 This technique easily delivers up to 400 000 (untrimmed/ redundant) insertion site sequences in a single run, which then need to be mapped and screened for redundancy. We saw that the large sequence set derived from pyrosequencing was analyzed nearly 10 times faster by our tool than sequences that were generated by conventional (Sanger) sequencing. For technical reasons, pyrosequencing generates shorter nucleotide sequences (compared with those obtained by Sanger sequencing). Yet, as future insertion site studies will heavily rely on this technique, we decided to address this and implemented a BLAT into QuickMap. The BLAT algorithm is known to process short query sequences more efficiently than the long ones, 51 resulting in a 10 times higher mapping speed for sequences obtained from pyrosequencing.
Taken together, we have described the establishment, application and validation of a fast, novel and standardized analysis pipeline. Together with the GTSG.org database, which up to now stores more than 50 000 unique gene therapy vector insertion sites, this setup can reliably serve as a suitable storage/analyzing system for a constantly growing number of insertion site sequences arising from future clinical and non-clinical gene therapy trials. Its open-access character allows a fast generation of standardized gene therapy vector profiles wherever new insertion site sequences are generated, and will thus contribute to identify safer vectors for clinical gene therapy studies.
Materials and methods

Generation of random sequences for a simulation of random insertion
To obtain insertion site sequences for simulating random insertion, we developed a java-based application (Sun Microsystems Inc., Santa Clara, CA, USA), which randomly retrieves base positions from a virtual strand of the human genome. This virtual strand is generated by merging the sequences of all 24 chromosomes, in which Automated vector insertion site analysis J-U Appelt et al each single base is a potential candidate for a random insertion position. Once a randomly chosen position within this virtual strand was translated back into a chromosomal position, the strand polarity was randomly chosen, and a slice of 100 bp was extracted downstream to this site. The current assembly of the human genome also consists of several 'gaps', that is, to date undetermined parts, predominantly occurring near the centromere regions. Possible insertions within these sites may also be detected by methods such as LM-PCR/LAM-PCR, but cannot be mapped to the genome and need to be filtered out. To apply the same filter conditions to the random set, we examined the randomly chosen sequences in terms of appearance of undefined bases Mapping time. 152 426 human immunodeficiency virus (HIV) (gray triangles) and 5739 murine leukemia virus (MLV) (black squares) insertion site sequences were subjected to QuickMap and mapping time was measured for each sequence set and a trend line was drawn. Two types of sequence sets can be distinguished: sequences generated using conventional (Sanger) sequencing and sequences obtained from pyrosequencing. 
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Mapping raw data
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Comparison to random set Figure 6 QuickMap analysis pipeline. Insertion site sequences entered by users through www.gtsg.org are subjected to the QuickMap analysis pipeline. QuickMap first maps insertion site sequences and calculated genomic positions using a BLAST-like alignment tool (BLAT). Profiles of the insertion locus are then constructed by extracting all genomic features (Genes, TSS, transcription factor binding sites and so on) from a 'slice', which is built around this genomic position. All profiles are then automatically compared to data obtained from random sequence set profiles and written into five different reports (Basic Report, Gene report, Regulatory Feature Report, Repeat Feature Report and Simple Feature Report). Although all raw mapping data are compiled in the MapperReport, the results of the analysis against the random set are written into the AnalyzerReport. Both reports are then automatically sent to the e-mail address provided by the user.
Automated vector insertion site analysis J-U Appelt et al ('N'), indicating a sequence gap. Since all extracted random sequences are 100 bp of length, a BLAST/BLAT query sequence can contain up to 13 (13%) unknown residues (Ns) until the corresponding BLAST/BLAT score reduces to 48% of the maximum score (matched nucleotide: +1, mismatched nucleotide À4; max score of 100 bp query: 100, see NCBI Handbook: http://blast. ncbi.nlm.nih.gov/Blast). Thus, all randomly extracted sequences that contained more than 10% Ns were judged to be gap sequences and were discarded.
Calculation of random insertion
For the calculation, we determined expected random insertion frequencies by comparing the cumulative length of four selected features (genes, CpG islands, transcription factor binding sites and repetitive elements) with the length of the human genome (B3.08 Â 10 9 bp; www.ensembl.org/Homo_sapiens/). Thus, the expected frequencies exactly reflect a feature's (gene, CpG island, transcription factor binding site and repetitive element) proportion on the human genome.
Comparison of calculation and simulation of random insertion
We designed a strategy to compare both approaches, whereas four groups of sets ranging from 1000 to 1 000 000 random positions were tested. For each of the four groups, we first calculated the expected insertion frequencies in genes, cancer genes, transcription factor binding sites and repeat elements (containing SINE, LINE and LTR elements). For the simulation, 25 sets of random sequences were produced for each of the four assemblages (set 1: 25 Â 1000 random sequences, set 2: 25 Â 10 000 random sequences, set 3: 25 Â 100 000 random sequences and set 4: 25 Â 1 000 000 random sequences). Insertion frequencies in the above named groups were then measured. For both, calculated and simulated insertion frequencies, we determined 95% CIs using the Clopper-Pearson method 52 calculated by a script of the statistical programming environment R (the R Development Team, www.R-project.org). If the CIs of the experimental and random frequencies did not overlap, we additionally tested for significance using an exact binomial test.
QuickMap web interface and software
We used a web server running Apache Tomcat (Version 5.5.23, http://tomcat.apache.org/), which hosts a JavaServer Pages/servlet driven web interface (JSP; Sun Microsystems Inc.), accessible through www.gtsg.org. All vector insertion site sequences uploaded through the web interface are temporarily stored on a server running MySQL (Version 4.1.22, http://www.mysql.com/), which also runs local installations of the ENSEMBL 42, 48 and 52 drafts of the human and mouse genomes (http://www.ensembl.org/info/data/download.html). To allow comparisons with analyses carried out with older genome versions, selection of one of these three drafts is enabled (drop-down menu). Finally, an application server implemented in Java (JDK 6.0, Sun Microsystems; http://www.sun.com/java/) was installed, which runs QuickMap.
QuickMap-based mapping
Query sequences entered at the web interface (http:// www.gtsg.org) are initially mapped to the human or murine genomes by using BLAT. 51 BLAT hits were only accepted if the query sequences were reliably and unambiguously aligned to the target genome. Reliability is given if the score exceeds 50% of the maximum reachable score (high scoring hits, see NCBI Handbook: http://blast.ncbi.nlm.nih.gov/Blast). Unambiguity was assumed if the secondary hits had BLAT scores o90% of the primary hit score. After mapping of the sequences to certain chromosomal positions and selection of the best BLAT hit, an algorithm of the IntegrationMap task 19 defines the first base of the sequences as the insertion base (that is, the vector-flanking base). Then, a broad variety of genomic features (genes, transcription start sites, transcription factor binding sites, CpG islands and so on, see Figure 1 ) is extracted from a genomic window ('slice') of +/À 250 kb around this insertion base, whereas plus and minus strands are analyzed separately. Next, individual distances of these features to the insertion base (in base pairs) are calculated. All data are then exported into separate report sheets, which are stored in Microsoft Excel (Microsoft Deutschland GmbH, Unterschleissheim, Germany) compatible files that are then further compressed in a single zip-file, termed MapperReport.
QuickMap-based measurement of insertion frequencies
QuickMap initially screens for redundant insertion sites within the sequence set that is submitted at the web interface using standard quality filter criteria described before. 42 Following redundancy control, two frequencies of insertions are measured: hit and adjacent insertion frequency. For calculating the hit frequency, QuickMap detects all insertion bases that lie within the genomic start and end bases of a feature (gene, cancer gene, SINE, LINE and so on). Next, for the calculation of adjacent features, the tool screens discrete distance steps ('bins') of 1 kb size around the insertion site. A total of 500 bins are screened (250 upstream and 250 downstream of the insertion). For each insertion frequency detected for a feature located in a bin, the corresponding 95% CI is automatically calculated using the Clopper-Pearson method. Together with hit and adjacent frequencies calculated for n ¼ 1 000 000 random sequences, all data determined for insertion site sequences entered at the web interface are then written in separate report sheets of Microsoft Excel (Microsoft) files. Similar to the MapperReport, the program generates a zip-compressed AnalyzerReport. A workflow of QuickMap analyses is shown in Figure 6 .
Implementation of cancer genes and fragile sites
The QuickMap task uses the ENSEMBL 42, 48 and 52 drafts of the human and mouse genomes, respectively, which do not store information about cancer genes and fragile sites. These features therefore needed to be separately implemented into the mapping and analyses procedures of QuickMap. To calculate frequencies of hits in and adjacent to cancer genes, we downloaded the genes listed in two cancer gene databases: the cancer gene census 46 (human cancer genes) or the RTCGD (mouse cancer genes). 53 As RTCGD genes are annotated as MGI IDs, conversion to ENSEMBL IDs was achieved Automated vector insertion site analysis J-U Appelt et al using BIOMART (http://www.ensembl.org/biomart/ martview).
For analyses of fragile sites, we imported chromosomal start and end positions of all the 120 known fragile sites from the NCBI database (http://www.ncbi.nlm. nih.gov) and QuickMap located vector insertions within these given boundaries.
Sequences subjected to QuickMap 5739 murine leukemia virus and 152 426 human immunodeficiency virus insertion site sequences stored in the GTSG.org database (see www.gtsg.org for details) were used to evaluate mapping time. These sequences were either derived from studies of our group, were downloaded from the NCBI database (http://www. ncbi.nlm.nih.gov/entrez/query.fcgi?db ¼ Nucleotide) if an accession number was published, or were contributed directly by the corresponding authors of the paper.
Removal of vector/non-genomic sequences
Prior to upload into QuickMap, all sequences were subjected to quality control to enable uniform analysis. Known LTR and/or cloning vector plasmid sequences that arose from LAM-PCR, LM-PCR, or inverse PCR were removed using the IntegrationSeq tool 19 (hyperlink available at www.gtsg.org). Together with vector and adapter sequences, FASTA or chromatogram files (trace files) were uploaded into IntegrationSeq (http://genius.embnet.dkfz-heidelberg.de/menu/biounit/ open-husar). The program was started and automatically removed all vector, LTR, adapter/linker and other associated non-genomic sequences. The remaining sequence between LTR positions and adapter sequence was available in an GCG-formatted output file, which was then converted to FASTA using TOFASTA from the W3H task system. 54 If the vector/LTR sequences were unknown, the VecScreen tool of the NCBI (http://www.ncbi.nlm.nih.gov/ VecScreen/VecScreen.html) was used to remove vector/ LTR sequences.
